Alembic Pharmaceuticals Limited (NSE: APLLTD)

Market Cap	217.34B
Revenue (ttm)	63.04B
Net Income (ttm)	6.30B
Shares Out	196.56M
EPS (ttm)	32.03
PE Ratio	34.53
Forward PE	29.73
Dividend	11.00 (0.99%)
Ex-Dividend Date	Jul 15, 2024

Volume	387,898
Open	1,156.00
Previous Close	1,147.15
Day's Range	1,101.25 - 1,174.90
52-Week Range	707.15 - 1,284.95
Beta	0.66
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Alembic Pharmaceuticals

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1907
• Employees: 14,858
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: APLLTD

Financial Performance

In 2023, APLLTD's revenue was 62.29 billion, an increase of 10.19% compared to the previous year's 56.53 billion. Earnings were 6.16 billion, an increase of 80.07%.